SMTL ID : 8i7l.1

Crystal structure of indoleamine 2,3-dioxygenagse 1 (IDO1) complexed with a novel inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

homo-dimer

Ligands

1 x THJ: THIOSULFATE(Non-covalent)

THJ.1: 1 residues within 4Å: Chain A: R.193 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.193

2 x OIH: 1-[3-[(4-chloranyl-2-fluoranyl-phenyl)carbamoylamino]-4-[cyclohexyl(2-methylpropyl)amino]phenyl]pyrrole-2-carboxylic acid(Non-covalent)

OIH.2: 19 residues within 4Å: Chain A: Y.126, C.129, V.130, F.163, F.164, V.166, S.167, V.170, F.214, I.217, L.234, G.262, S.263, A.264, H.346, I.349, V.350, I.354, L.384 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:Y.126, A:V.130, A:V.166, A:V.170, A:V.170, A:F.214, A:F.214, A:I.217, A:I.217, A:L.234, A:A.264, A:I.349, A:V.350, A:I.354, A:L.384 Hydrogen bonds: A:S.167, A:S.167, A:S.167 Water bridges: A:A.264, A:A.264 Salt bridges: A:H.346 OIH.3: 19 residues within 4Å: Chain B: Y.126, C.129, V.130, F.163, F.164, V.166, S.167, V.170, F.214, I.217, F.226, L.234, G.262, S.263, A.264, F.270, H.346, I.349, I.354 19 PLIP interactions: 19 interactions with chain B Hydrophobic interactions: B:V.130, B:V.166, B:V.170, B:F.214, B:I.217, B:F.226, B:A.264, B:F.270, B:I.349, B:I.354 Hydrogen bonds: B:S.167, B:S.167, B:S.167 Water bridges: B:G.262, B:A.264, B:A.264 Salt bridges: B:H.346 pi-Stacking: B:Y.126 Halogen bonds: B:F.163

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, W. et al., Apo-Form Selective Inhibition of IDO for Tumor Immunotherapy. J Immunol. (2022)

Release Date

2023-02-15

Peptides

Indoleamine 2,3-dioxygenase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Indoleamine 2,3-dioxygenase 1

Related Entries With Identical Sequence